Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1182/BLOOD.V63.1.42.42PMID 6606454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III

  1985cited by this paper
• The binding of bovine factor XII to kaolin.

  1983cited by this paper
• New and rapid functional assay for C1 inhibitor in human plasma.

  1982cited by this paper
• Assay of prekallikrein in human plasma: comparison of amidolytic, esterolytic, coagulation, and immunochemical assays.

  1982cited by this paper
• Factor XI assay results in the CAP survey (1981).

  1982cited by this paper
• Acquired antibody to factor XI in a patient with congenital factor XI deficiency.

  1982cited by this paper
• Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.

  1982cited by this paper
• Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.

  1982cited by this paper
• Properties of sulfatides in factor-XII-dependent contact activation.

  1982cited by this paper
• Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III.

  1982cited by this paper
• Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI.

  1979cited by this paper
• Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.

  1978cited by this paper
• Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay.

  1977cited by this paper
• Contact activation of factor XI: evidence that the primary role of contact activation cofactor (CAC) is to facilitate the activation of factor XII.

  1977cited by this paper
• Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.

  1977cited by this paper
• Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay. [/sup 125/I tracer technique]

  1977cited by this paper
• Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.

  1976cited by this paper
• Partial purification and characterization of contact activation cofactor.

  1975cited by this paper
• SUBSTRATES OF HAGEMAN FACTOR

  1974cited by this paper
• Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.

  1974cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Cleavage of structural proteins during

  1970cited by this paper
• Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

  1969cited by this paper
• Interaction of soybean trypsin inhibitor with thrombin and its effect on prothrombin activation.

  1969cited by this paper
• ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

  1964cited by this paper
• THE INTERRELATIONSHIP OF COAGULATION OF PLASMA AND RELEASE OF PEPTIDES

  1963cited by this paper
• The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

  1961cited by this paper
• Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

  1961cited by this paper

• Activity Sensing of Coagulation and Fibrinolytic Proteases.

  2022cites this paper
• Avaliação da presença do Fator XI de coagulação em preparações de imunoglobulina G para uso intravenoso.

  2014cites this paper
• Alpha-1-antitrypsin-Pittsburgh A Potent Inhibitor of Human Plasma Factor XIa , Kallikrein , and Factor

  2013cites this paper
• Coagulation Factor XIa

  2013cites this paper
• Clotting Factors and Inhibitors: Assays and Interpretation

  2012cites this paper
• XIa activity on the platelet surface Functional characterization of platelet-bound factor XIa: retention of factor

  2011cites this paper
• Plasminogen activator activity is inhibited while neuroserpin is up‐regulated in the Alzheimer disease brain

  2009cites this paper
• Recombinant cx1-Antitrypsin Pittsburgh Attenuates Experimental Grar-Negative Septicem ia

  2007cites this paper
• Chromogenic methods in coagulation diagnostics

  2005cites this paper
• Activation of human coagulation system by liver-derived clotting factors of Banna minipig inbred line.

  2004cites this paper
• Elevated hemostatic factor levels as potential risk factors for thrombosis.

  2002cites this paper
• Selection and characterization of a novel factor XI inhibiting peptide by using phage display technology

  2002cites this paper
• A Binding Site for the Kringle II Domain of Prothrombin in the Apple 1 Domain of Factor XI*

  2000cites this paper
• Thrombin-mediated Feedback Activation of Factor XI on the Activated Platelet Surface Is Preferred over Contact Activation by Factor XIIa or Factor XIa*

  2000cites this paper
• The Role of Factor XI in Coagulation: A Matter of Revision

  1999cites this paper
• Faktor XI: Physiologie, Biochemie, Molekularbiologie

  1999cites this paper
• Phosphorylation of Coagulation Factor XI by a Casein Kinase Released by Activated Human Platelets Increases Its Susceptibility to Activation by Factor XIIa and Thrombin

  1999cites this paper
• Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.

  1998cites this paper
• A Binding Site for Thrombin in the Apple 1 Domain of Factor XI (*)

  1996cites this paper
• Effect of Heparin on the Activation of Factor XI by Fibrin-bound Thrombin

  1996cites this paper
• Purification, Characterization and cDNA Cloning of a Novel Anticoagulant of the Intrinsic Pathway, (Prolixin-S), from Salivary Glands of the Blood Sucking Bug, Rhodnius prolixus

  1996cites this paper
• Identification and Characterization of a Binding Site for Platelets in the Apple 3 Domain of Coagulation Factor XI (*)

  1995cites this paper
• Factor XI deficiency in an Ashkenazi Jewish child, causing severe postoperative hemorrhage.

  1995cites this paper
• Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.

  1995cites this paper
• The Apple 1 and Apple 4 domains of factor XI act synergistically to promote the surface-mediated activation of factor XI by factor XIIa.

  1995cites this paper
• Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.

  1994cites this paper
• Calcium threshold in human plasma clotting kinetics.

  1994cites this paper
• Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.

  1994cites this paper
• Factor XI: structure-function relationships utilizing monoclonal antibodies protein modification, computational chemistry, and rational synthetic peptide design.

  1993cites this paper
• Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.

  1992cites this paper
• Fine mapping of the high molecular weight kininogen binding site on blood coagulation factor XI through the use of rationally designed synthetic analogs.

  1992cites this paper
• A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.

  1992cites this paper
• Contact factor proteases and the complexes formed with α2-macroglobulin can interfere in protein C assays by cleaving amidolytic substrates

  1992cites this paper
• Binding of coagulation factor XIa to receptor on human platelets.

  1992cites this paper
• Chromogenic peptide substrate assays and their clinical applications.

  1991cites this paper
• Factor XI activation in a revised model of blood coagulation

  1991cites this paper
• Identification and chemical synthesis of a substrate-binding site for factor IX on coagulation factor XIa.

  1991cites this paper
• Factor XI: A Review of Its Biochemistry and Deficiency

  1991cites this paper
• Test systems with synthetic peptide substrates in haemostaseology.

  1991cites this paper
• Characterization of a Panel of Monoclonal Antibodies to Human Coagulation Factor XI and Detection of Factor XI in Hep G2 Cell Conditioned Medium

  1990cites this paper
• Purification and characterization of platelet factor XI.

  1990cites this paper
• Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86.

  1990cites this paper
• Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.

  1989cites this paper
• Conformation of high molecular weight kininogen: effects of kallikrein and factor XIa cleavage.

  1989cites this paper
• Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.

  1989cites this paper
• Effect of Heparin on the Inhibition of the Contact System Enzymes

  1989cites this paper
• Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.

  1988cites this paper
• RECOMBINANT ALPHA-1-ANTITRYPSIN PITTSBURGH ATTENUATES EXPERIMENTAL GRAM-NEGATIVE SEPTICEMIA

  1988cites this paper
• A simple and accurate microplate assay for the determination of factor XI in plasma.

  1988cites this paper
• A rapid enzyme-linked immunosorbent assay for human factor XI.

  1988cites this paper
• A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.

  1987cites this paper
• Contact Factors in Health and Disease

  1987cites this paper
• Identification of a defective factor XI cross-reacting material in a factor XI-deficient patient.

  1987cites this paper
• Enzyme-linked coagulation assay. III. Sensitive immunoassays for clotting factors II, VII, and X.

  1987cites this paper
• Enzyme-linked coagulation assay. II. A sensitive assay for tissue factor and factors II, VII, and X.

  1987cites this paper
• A new sensitive assay for bovine activated factor XI (factor XIa) using a reconstituted coagulation cascade system.

  1987cites this paper
• Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.

  1987cites this paper
• Biochemical and Functional Properties of Factor XI and Prekallikrein

  1987cites this paper
• Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.

  1986cites this paper
• Assay of kallikrein inhibitors and levels of acetone-activated kallikrein in plasma specimens from reactors to dextran or to contrast media.

  1986cites this paper
• Human factor XIa cleaves fibrinogen: effects on structure and function.

  1986cites this paper
• Failure of Routine Coagulation Screening Tests to Detect Heterozygous State of Bovine Factor XI Deficiency.

  1986cites this paper
• Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein.

  1986cites this paper
• Factor XIa-alpha 1 antitrypsin complex--elevation in the patients with DIC.

  1986cites this paper
• Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.

  1986cites this paper
• Synthetic peptide substrate assays for hemostasis testing.

  1986cites this paper
• Murine monoclonal antibodies to human factor XI.

  1986cites this paper
• The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.

  1986cites this paper
• Factor XIa-α1antitrypsin complex — Elevation in the patients with DIC —

  1986cites this paper
• Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome.

  1985cites this paper
• Blood Coagulation and Fibrinolysis

  1985cites this paper
• Evaluation von Methoden und Methoden-Reagenzien-Kombinationen

  1985cites this paper
• Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function.

  1985cites this paper
• Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds

  1985cites this paper
• Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.

  1985cites this paper
• Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds.

  1985cites this paper
• Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds.

  1985cites this paper
• Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.

  1984cites this paper
• Regulation of the coagulant activity and surface binding of high molecular weight kininogen.

  1984cites this paper
• Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.

  1984cites this paper
• Alpha-1 -antitrypsin-Pittsburgh A Potent Inhibitor of Human Plasma Factor XIa, Kallikrein, and Factor Xllf

  year unknowncites this paper